Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment

Upsala Journal of Medical Sciences

Volumn 109, Issue 3, 2004, Pages 247-254

  Hallberg, Pär ^a   Melhus, Håkan ^a   Hansson, Lars Olof ^a   Larsson, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Creatinine; Cystatin C; Digoxin; Glomerular filtraten rate; Kidney

Indexed keywords

BIOCHEMICAL MARKER; CREATININE; CYSTATIN C; DIGOXIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIGOXIN BLOOD LEVEL; DRUG MONITORING; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; PROTEIN BLOOD LEVEL;

EID: 5144221809     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-087     Document Type: Article

References (27)

1. Rathore, S.S., Wang, Y. and Krumholz, H.M. 2002. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 18: 1403-1411.
2. Hallberg, P., Michaelsson, K. and Melhus, H. 2003. Digoxin for the treatment of heart failure. N Engl J Med 7: 661-663; author reply 661-663.
3. Rathore, S.S., Curtis, J.P., Wang, Y., Bristow, M.R. and Krumholz, H.M. 2003. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 7: 871-878.
4. Mjorndal, T., Boman, M.D., Hagg, S., Backstrom, M., Wiholm, B.E., Wahlin, A. and Dahlqvist, R. 2002. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 1: 65-72.
5. Lindley, C.M., Tully, M.P., Paramsothy, V. and Tallis, R.C. 1992. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 4: 294-300.
6. Gray, S.L., Sager, M., Lestico, M.R. and Jalaluddin, M. 1998. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci 1: M59-63.
7. Hanlon, J.T., Schmader, K.E., Koronkowski, M.J., Weinberger, M., Landsman, P.B., Samsa, G.P. and Lewis, I.K. 1997. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 8: 945-948.
8. Juurlink, D.N., Mamdani, M., Kopp, A., Laupacis, A. and Redelmeier, D.A. 2003. Drug-drug interactions among elderly patients hospitalized for drug toxicity. Jama 13: 1652-1658.
9. Wills, P., Fastbom, J., Claesson, C.B., Cornelius, C., Thorslund, M. and Winblad, B. 1996. Use of cardiovascular drugs in an older Swedish population. J Am Geriatr Soc 1: 54-60.
10. Steimer, W., Muller, C. and Eber, B. 2002. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids. Clin Chem 3: 507-516.
11. Jortani, S.A. and Valdes, R., Jr. 1997. Digoxin and its related endogenous factors. Crit Rev Clin Lab Sci 3: 225-274.
12. Mooradian, A.D. 1988. Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations. Clin Pharmacokinet 3: 165-179.
13. Kemperman, F.A., Krediet, R.T. and Arisz, L. 2002. Formula-derived prediction of the glomerular filtration rate from plasma creatinine concentration. Nephron 4: 547-558.
14. Schwartz, G.J., Haycock, G.B., Edelmann, C.M., Jr. and Spitzer, A. 1976. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 2: 259-263.
15. Hsu, C.Y., Chertow, G.M. and Curhan, G.C. 2002. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 5: 1567-1576.
16. Sherman, D.S., Fish, D.N. and Teitelbaum, I. 2003. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2: 269-278.
17. Grubb, A.O. 2000. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 35: 63-99.
18. Grubb, A., Simonsen, O., Sturfelt, G., Truedsson, L. and Thysell, H. 1985. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 5: 499-503.
19. Filler, G., Priem, F., Lepage, N., Sinha, P., Vollmer, I., Clark, H., Keely, E., Matzinger, M., Akbari, A., Althaus, H. and Jung. K. 2002. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem 5: 729-736.
20. Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J. and Turk, V. 1988. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. Embo J 8: 2593-2599.
21. Tenstad, O., Roald, A.B., Grubb, A. and Aukland, K. 1996. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 5: 409-414.
22. Dharnidharka, V.R., Kwon, C. and Stevens, G. 2002. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2: 221-226.
23. O'Riordan, S., Ouldred, E., Brice, S., Jackson, S.H. and Swift, C.G. 2002. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. Br J Clin Pharmacol 4: 398-402.
24. Price, C.P. and Finney, H. 2000. Developments in the assessment of glomerular filtration rate. Clin Chim Acta 1-2: 55-66.
25. Cockcroft, D.W. and Gault, M.H. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 1: 31-41.
26. Leader, W.G., Tsubaki, T. and Chandler, M.H. 1994. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients. Am J Hosp Pharm 17: 2125-2130.
27. Verhave, J.C., Balje-Volkers, C.P., Hillege, H.L., de Zeeuw D,. and de Jong, P.E. 2003. The reliability of different formulae to predict creatinine clearance. J Intern Med 5: 563-573.